Topic resource collection
Approved comparison material connected to this topic.
9 resourcesRead both sides
Peptides for Leaky Gut Compared — Real Healing vs Hype BPC-157, thymosin beta-4, and collagen peptides differ significantly in gut barrier repair mechanisms — absorption rates and clinical evidence vary by A 2023 systematic revie…
Before interpreting this table, understand that peptide research for gut permeability exists primarily in preclinical models and Phase 1–2 human trials. No peptide discussed here has completed Phase 3 FDA approval specifically fo…
Research peptides for gut restoration fall into two mechanistic categories that operate through distinct biological pathways. Epithelial repair peptides. BPC-157, TB-500 (Thymosin Beta-4), and GHK-Cu. Upregulate growth factors (V…
The fundamental misunderstanding about peptides for leaky gut compared centres on the difference between signalling molecules and building blocks. Intestinal hyperpermeability. The clinical term for 'leaky gut'. Occurs when tight…
A 2023 systematic review published in the Journal of Clinical Gastroenterology found that peptide-based interventions targeting intestinal permeability showed measurable reductions in zonulin levels. The primary biomarker for com…
BPC-157 VEGF upregulation, collagen synthesis, tight junction protein expression (occludin, claudin) 500–1000 mcg daily (split into 2 doses) 4–6 hours Subcutaneous (lower abdomen preferred) Gold standard for structural gut repair…
BPC-157 Upregulates VEGF and FGF-2 for mucosal healing; restores tight junction protein synthesis 250–500 mcg/day Subcutaneous or oral Animal models (robust); human data (limited) Strongest mechanistic evidence for structural bar…
The gap between a research-grade peptide and a consumer gut-healing supplement isn't just purity. It's verifiable identity and potency. L-glutamine, the most commonly recommended amino acid for intestinal repair, provides substra…
BPC-157 Tight junction stabilisation via VEGF upregulation and occludin expression 250–500mcg daily subcutaneous or oral 2–4 weeks for permeability reduction Preclinical rodent models; limited human data Strongest evidence for di…